Scott Biller

2017

In 2017, Scott Biller earned a total compensation of $2.3M as Chief Scientific Officer at Agios Pharmaceuticals, a 32% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$223,287
Option Awards$1,639,353
Salary$429,397
Other$9,840
Total$2,301,877

Biller received $1.6M in option awards, accounting for 71% of the total pay in 2017.

Biller also received $223.3K in non-equity incentive plan, $429.4K in salary and $9.8K in other compensation.

Rankings

In 2017, Scott Biller's compensation ranked 4,824th out of 14,666 executives tracked by ExecPay. In other words, Biller earned more than 67.1% of executives.

ClassificationRankingPercentile
All
4,824
out of 14,666
67th
Division
Manufacturing
1,717
out of 5,768
70th
Major group
Chemicals And Allied Products
510
out of 2,074
75th
Industry group
Drugs
394
out of 1,730
77th
Industry
Pharmaceutical Preparations
313
out of 1,329
76th
Source: SEC filing on April 18, 2018.

Biller's colleagues

We found four more compensation records of executives who worked with Scott Biller at Agios Pharmaceuticals in 2017.

2017

David Schenkein

Agios Pharmaceuticals

Chief Executive Officer

2017

Christopher Bowden

Agios Pharmaceuticals

Chief Medical Officer

2017

Andrew Hirsch

Agios Pharmaceuticals

Chief Financial Officer

2017

Steve Hoerter

Agios Pharmaceuticals

Chief Commercial Officer

News

In-depth

You may also like